Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Total Assets (Quarterly) : 18.97M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.97M |
| March 31, 2026 | 29.69M |
| December 31, 2025 | 20.48M |
| September 30, 2025 | 27.64M |
| June 30, 2025 | 29.23M |
| March 31, 2025 | 39.33M |
| December 31, 2024 | 42.13M |
| September 30, 2024 | 42.47M |
| June 30, 2024 | 50.41M |
| March 31, 2024 | 62.02M |
| December 31, 2023 | 78.12M |
| September 30, 2023 | 89.98M |
| June 30, 2023 | 84.31M |
| March 31, 2023 | 94.54M |
| December 31, 2022 | 110.04M |
| September 30, 2022 | 122.85M |
| June 30, 2022 | 128.83M |
| March 31, 2022 | 140.74M |
| December 31, 2021 | 163.86M |
| September 30, 2021 | 172.09M |
| June 30, 2021 | 181.19M |
| March 31, 2021 | 190.59M |
| December 31, 2020 | 206.15M |
| September 30, 2020 | 45.71M |
| June 30, 2020 | 44.95M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.71M |
| December 31, 2019 | 35.15M |
| September 30, 2019 | 42.24M |
| June 30, 2019 | 48.24M |
| March 31, 2019 | 55.45M |
| December 31, 2018 | 37.36M |
| September 30, 2018 | 44.26M |
| June 30, 2018 | 53.19M |
| March 31, 2018 | 61.38M |
| December 31, 2017 | 73.80M |
| September 30, 2017 | 82.37M |
| June 30, 2017 | 63.80M |
| March 31, 2017 | 73.76M |
| December 31, 2016 | 57.75M |
| September 30, 2016 | 66.19M |
| June 30, 2016 | 74.10M |
| March 31, 2016 | 85.32M |
| December 31, 2015 | 94.97M |
| September 30, 2015 | 106.11M |
| June 30, 2015 | 111.58M |
| March 31, 2015 | 119.31M |
| December 31, 2014 | 62.61M |
| September 30, 2014 | 68.21M |
| June 30, 2014 | 73.90M |
| March 31, 2014 | 75.36M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.28M |
| Shareholders Equity (Quarterly) | 4.695M |
| Debt to Equity Ratio | 0.2224 |
| Current Ratio | 0.4917 |
| Net Debt Paydown Yield | 32.73% |